Last reviewed · How we verify
Prevention of venous thromboembolism
Approved treatments
- Lovenox (Preservative Free) · Sanofi
Lovenox works by enhancing the activity of antithrombin-III to inhibit blood clotting. - Lovenox · University of Monastir
- Enoxaparin · Dana-Farber Cancer Institute
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of venous thromboembolism patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of venous thromboembolism treatment landscape brief
- Prevention of venous thromboembolism treatment updates RSS
Frequently asked questions about Prevention of venous thromboembolism
What drugs treat Prevention of venous thromboembolism?
Tracked treatments include Lovenox (Preservative Free), Lovenox, Enoxaparin.
What is the treatment for Prevention of venous thromboembolism?
Standard treatment for Prevention of venous thromboembolism includes Lovenox (Preservative Free), Lovenox, Enoxaparin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of venous thromboembolism patent cliff · Prevention of venous thromboembolism CI report
- Treatment: Lovenox (Preservative Free) · Sanofi
- Treatment: Lovenox · University of Monastir
- Treatment: Enoxaparin · Dana-Farber Cancer Institute
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing